MYROBALAN THERAPEUTICS

Myrobalan Therapeutics is a CNS-focused pre-clinical biotech company developing medicines to address the unmet need and societal burdens of neurodegenerative and demyelinating disorders. We focus our efforts on targeting specialized cells in the CNS, such as microglia and oligodendrocytes, which play crucial roles in maintaining nervous system health and function. We are committed to transforming the future for patients with neurological diseases through the development of safe and effective precision medicines that restore brain health under the guidance of biomarkers... Our goal is to restore brain function by addressing critical disease mechanisms common to major CNS disorders. Our potentially first-in-class and best-in-class small molecule CNS therapies promote remyelination and address neuroinflammation to combat neurological diseases such as multiple sclerosis, Alzheimer's disease, ALS, Parkinson's disease, and other demyelinating and neurodegenerative disorders... We strive to..

Also known as: Myro Therapeutics, Inc., Myrobalan Therapeutics, Inc.

Primary location: Medford United States